New York startup Helaina, which ferments microbes to create recombinant breast milk proteins, is ushering in a new dawn for ...
Savara Inc. (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the amendment of its loan and security agreement with Hercules Capital, Inc.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results